Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)
Jennifer E. Adair(North Seattle College), Boro Dropulić(Capital Caring), Els Verhoeyen(Université Claude Bernard Lyon 1), Francis Ssali(Joint Clinical Research Centre), Lindsay Androski(Roivant Sciences (United States)), Evelyn Harlow(Ministry of Health), Alex Popovski(Roivant Sciences (United States)), Deus Bazira(Georgetown University), Rimas J. Orentas(Lentigen Technology (United States)), Lois Bayigga(Joint Clinical Research Centre), Umut A. Gürkan(Case Western Reserve University), Karine Dubé(University of California System), Lynda Dee(AIDS United), Michael Louella(Seattle University), Mark Dybul(Center for Global Health), Vikram Mathews(Christian Medical College, Vellore), Adrian McKemey(IQVIA (United States)), Olabimpe Olayiwola(Case Western Reserve University), Steven G. Deeks(University of California, San Francisco), Punam Malik(Cincinnati Children's Hospital Medical Center), Cissy Kityo(Joint Clinical Research Centre), Daniel Muyanja(Joint Clinical Research Centre), Moses Supercharger Nsubuga, Mohamed S. Draz(Case Western Reserve University), Henry Mugerwa(Joint Clinical Research Centre), Jeff Sheehy(Capital Caring), Eugene P. Brandon(IQVIA (United States)), John F. Tisdale(National Institutes of Health)
Cited by 39
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Systemic Effects of Inflammation on Health during Chronic HIV Infection
|Immunity|2013|835
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Defective proviruses rapidly accumulate during acute HIV-1 infection
|Nature Medicine|2016|774